TL;DR
This study investigates the long-term efficacy of using autologous platelet-rich plasma (PRP) as an adjunct to surgery for lamellar macular holes (LMH). The findings demonstrate that PRP significantly improves both the anatomical restoration of the fovea and visual acuity, suggesting a potential paradigm shift towards earlier surgical intervention for LMH.
What Problem Does This Paper Address?
Lamellar macular holes (LMH) are partial-thickness defects in the macula, a critical area of the retina responsible for sharp, central vision. These defects can lead to blurred vision, metamorphopsia (visual distortion), and a reduced quality of life. While surgical interventions like pars plana vitrectomy with internal limiting membrane (ILM) peeling are standard for full-thickness macular holes, their application and efficacy for LMHs, particularly regarding long-term outcomes and the prevention of progression to more severe forms, remain subjects of ongoing discussion and research. Specifically, the role of adjunct therapies in optimizing outcomes and preventing recurrence or progression is an area needing further clarification.
Methods
The study employed an interventional case series design involving 19 patients with symptomatic and progressive LMHs. The core surgical procedure was a 23- or 25-gauge pars plana vitrectomy, which involved inducing posterior vitreous detachment and peeling of epiretinal membranes and the ILM (with two exceptions). The novel aspect was the intraoperative application of 0.1 mL of highly concentrated autologous platelet-rich plasma (PRP) to the posterior pole, typically under air tamponade. For phakic patients, a combined phacovitrectomy was performed. Postoperatively, patients were instructed to maintain a supine position for two hours. Assessments included best-corrected visual acuity (BCVA), microperimetry, and spectral domain optical coherence tomography (SD-OCT), conducted preoperatively and at a minimum of 6 months post-surgery (median 12 months).
Datasets
Not discussed in the paper.
Key Insights and Ideas
- PRP as a potent regenerative adjunct: The study strongly suggests that PRP, when used in conjunction with standard LMH surgery, actively promotes healing and structural restoration of the fovea, going beyond what is achieved with surgery alone.
- Importance of ILM peeling: The recurrence of defects in the two patients who did not undergo ILM peeling highlights the critical role of this step in allowing PRP to interact with the underlying retinal tissue and facilitate healing. This implies PRP needs direct contact with the defect site to be effective.
- Prophylactic potential: The observed prevention of progression to full-thickness macular holes (FTMH) suggests that PRP might act as a prophylactic agent, safeguarding against further visual deterioration.
- Early intervention is key: The findings support the idea that addressing LMHs surgically, especially with adjuncts like PRP, earlier in their progression could lead to better long-term outcomes and prevent more severe vision loss.
Key Results
- Anatomical Restoration: Foveal configuration was restored in all 19 patients (100%) postoperatively.
- Visual Acuity Improvement: BCVA significantly improved from a preoperative average of 0.33 ± 0.15 logMAR to 0.18 ± 0.13 logMAR at the final follow-up (p = 0.001). This represents a substantial gain in visual acuity.
- Microperimetry: Microperimetry results remained largely unchanged, with a preoperative mean threshold of 23.39 ± 2.43 dB and 22.26 dB at follow-up (p = 0.51), indicating that while visual acuity improved, the sensitivity of the central retina did not significantly change.
- Recurrence: Two patients who did not undergo ILM peeling showed a recurring foveal defect at 6 months, though this did not lead to functional decline.
- Complications: No patients experienced vision loss, and no significant intra- or postoperative complications were observed. Postoperative cystoid macular edema occurred in 21% of eyes but was successfully treated.
Limitations and Future Work
The authors acknowledge several limitations, including the small sample size (19 patients), the lack of a control group, and the heterogeneous lens status of the patients (some phakic, some pseudophakic). They suggest that future studies should include prospective trials with homogenous, pseudophakic cohorts to eliminate confounding factors like cataract surgery. Further research is needed to compare different surgical techniques and adjuvant therapies to determine the most efficient approach for LMH treatment. The study's findings, however, strongly advocate for earlier surgical intervention in LMH patients, potentially shifting the paradigm in macular hole surgery.
Summary updated